A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS9531 Injection in Adolescents With Obesity

NCT07559136 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Overweight and Obesity

Interventions

DRUG: HRS9531 injection；Placebo
DRUG: HRS9531 injection；Placebo
DRUG: HRS9531 injection；Placebo

Sponsor

Fujian Shengdi Pharmaceutical Co., Ltd.